The effects of antifungal agents to conidial and hyphal forms ofAspergillus fumigatus
- 1 February 2010
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 48 (1) , 48-55
- https://doi.org/10.3109/13693780802713497
Abstract
Susceptibility testing for Aspergillus fumigatus is usually performed using a fungal conidial suspension. However, assessment of the susceptibility of fungal hyphae may be more relevant in attempting to mimic the fungal status in infected tissues. In the present study of 12 A. fumigatus clinical isolates and 1 ATCC strain, the antifungal susceptibilities of conidial suspensions, suspensions of hyphal fragments and of hyphal clumps were determined by the XTT-based broth susceptibility assay measuring decrease in fungal metabolic activity. Amphotericin B inhibited A. fumigatus conidia and hyphal fragments in a sharp concentration-dependent manner, with inhibitory concentrations (ICs) of 1 microg/ml for both fungal structures, whereas, hyphal clumps were inhibited at 8 microg/ml. Conidia and hyphal fragments were inhibited by the azoles itraconazole and voriconazole in a more gradual concentration-dependent manner, with ICs of 0.5 microg/ml for both structures with both agents. Hyphal clumps were not inhibited by the azoles at all. Caspofungin inhibited A. fumigatus in a moderate, neither sharp nor gradual, concentration-dependent manner. ICs for conidia were 128 microg/ml and inhibition in metabolic activity was not obtained for both hyphal growth forms. Antifungal susceptibility of conidia was also determined using the E-test in which it was found that the XTT assaygave comparable ICs for amphotericin B, itraconazole and voriconazole but not for caspofungin.Keywords
This publication has 26 references indexed in Scilit:
- Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatusJournal of Medical Microbiology, 2007
- Pathogenesis ofAspergillus fumigatusand the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal TherapyThe Journal of Infectious Diseases, 2007
- Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic AdjunctsClinical Infectious Diseases, 2007
- Invasive pulmonary aspergillosisExpert Review of Anti-infective Therapy, 2005
- Testing of the In Vitro Susceptibilities ofMadurella mycetomatisto Six Antifungal Agents by Using the Sensititre System in Comparison with a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5- [(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Assay and a Modified NCCLS MethodAntimicrobial Agents and Chemotherapy, 2005
- Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)Journal of Clinical Microbiology, 2003
- E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution MethodJournal of Clinical Microbiology, 2002
- In vitro studies on the activity of amphotericin B and lipid‐based amphotericin B formulations against Aspergillus conidia and hyphaeMycoses, 2002
- Colorimetric Assay for Antifungal Susceptibility Testing of Aspergillus SpeciesJournal of Clinical Microbiology, 2001
- Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp.Journal of Antimicrobial Chemotherapy, 2001